Drug Type Fusion protein |
Synonyms Ancrod (USAN/INN), NM-V, Viprinex |
Target |
Action inhibitors |
Mechanism Fibrinogen inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heparin-induced thrombocytopenia and thrombosis | NDA/BLA | United States | - | |
Acute Ischemic Stroke | Phase 3 | United States | 01 Sep 2005 | |
Acute Ischemic Stroke | Phase 3 | Australia | 01 Sep 2005 | |
Acute Ischemic Stroke | Phase 3 | Canada | 01 Sep 2005 | |
Acute Ischemic Stroke | Phase 3 | Czechia | 01 Sep 2005 | |
Acute Ischemic Stroke | Phase 3 | Netherlands | 01 Sep 2005 | |
Acute Ischemic Stroke | Phase 3 | Poland | 01 Sep 2005 | |
Acute Ischemic Stroke | Phase 3 | Russia | 01 Sep 2005 | |
Acute Ischemic Stroke | Phase 3 | South Africa | 01 Sep 2005 | |
Acute Ischemic Stroke | Phase 3 | Taiwan Province | 01 Sep 2005 |
Phase 3 | 1,222 | eqiidvxatg(ygbmuexjft) = qamzjrfrsi eeidgfrngk (vymueydlou ) | Negative | 25 Nov 2006 | |||
Placebo | eqiidvxatg(ygbmuexjft) = jyewjwqall eeidgfrngk (vymueydlou ) |